Italia markets close in 8 hours 21 minutes

T2 Biosystems, Inc. (0A57.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,0969+0,0053 (+5,79%)
Al 03:47PM BST. Mercato aperto.
Schermo intero
Chiusura precedente0,0916
Aperto0,0916
Denaro0,0000 x N/D
Lettera0,0000 x N/D
Min-Max giorno0,0969 - 0,1017
Intervallo di 52 settimane0,0969 - 0,1017
Volume6.800
Media VolumeN/D
CapitalizzazioneN/D
Beta (5 anni mensile)0,48
Rapporto PE (ttm)N/D
EPS (ttm)-0,3350
Prossima data utili02 nov 2022 - 07 nov 2022
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    T2 Biosystems Announces Commercial Expansion Through Distributor in Baltic Region

    LEXINGTON, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the execution of a territory exclusive distribution agreement in the Baltic Region, including Lithuania, Latvia, and Estonia. Under the terms of the agreement, T2 Biosystems will sell T2Dx® Instruments, along with T2Bacteria®, T2Candida® and T2Resistance® Panels through the distributor. The execution of

  • GlobeNewswire

    T2 Biosystems to Participate in the H.C. Wainwright Global Investment Conference

    LEXINGTON, Mass., Sept. 08, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced plans to participate in the upcoming H.C. Wainwright Global Investment Conference in New York, New York. Management is scheduled to present on Tuesday, September 13, 2022, at 3:00pm ET. Interested parties may access a live and recorded webcast of the presentation on the “Investors” section of the Compa

  • GlobeNewswire

    T2 Biosystems to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

    LEXINGTON, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced plans to present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Members of management are scheduled to present on Wednesday, August 31, 2022, at 11:30am ET. Interested parties can access a live webcast of the presentation directly by following this li